Alcon stock trades at EUR 57.02 with CHF 25.9 billion market value

Published on 10/09/2026 at 15:29 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Alcon stock costs EUR 57.02 on October 9, 2026 after EUR 56.35, plus 1.19 percent. The next report is November 10, 2026.

Key points in brief

Alcon stock traded at EUR 57.02 on October 9, 2026, up 1.19 percent from EUR 56.35 at Lang & Schwarz.
The SIX-listed shares stood 22.39 percent below their CHF 68.34 52-week high as of October 9, 2026.
Alcon had a CHF 25.9 billion market capitalization and a trailing P/E ratio of 48.56 on October 9, 2026.
Barclays initiated coverage with an Equal Weight rating and a USD 70.00 price target on October 6, 2026.

Photorealistic wide panoramic view of a modern ophthalmic surgery operating room. Surgical microscope centered, sterile metallic instruments arranged on blue drape, scrub-suited surgical team in background, cold overhead surgical lighting — Alcon CH0432492467: Augenchirurgie OP Saal mit Mikroskop, sterilen Werkzeugen und einem Operationsteam, Illustration mit AI erstellt.

Alcon stock was trading at EUR 57.02 at Lang & Schwarz on October 9, 2026 at 3:20 p.m. CEST, up 1.19 percent versus the prior close of EUR 56.35. The move puts the eye-care group at the center of a valuation and range check rather than a company-event review.

Yearly range leaves room

At the SIX Swiss Exchange, Alcon was last at CHF 53.04 on October 9, 2026 at 3:13 p.m. CEST, up 1.61 percent from CHF 52.20. The primary-market quote placed the stock between its CHF 47.80 52-week low and CHF 68.34 52-week high.

Alcon stood 10.96 percent above its 52-week low and 22.39 percent below its 52-week high on October 9, 2026. That positioning gives the daily euro gain context: the stock was higher on the session, but still well below its yearly peak.

Valuation and analyst target

Alcon had a CHF 25.9 billion market capitalization and a trailing P/E ratio of 48.56 on October 9, 2026. Its trailing dividend yield was 0.01 percent, leaving earnings valuation as the more visible market metric.

According to Business Insider on October 6, 2026, Barclays analyst Christopher Pasquale initiated coverage with an Equal Weight rating and a USD 70.00 price target. The target provides a separate dollar-based reference and is not combined with the euro quotation.

Comparison with peers

Alcon: plus 1.19 percent, P/E 48.56, market capitalization CHF 25.9 billion

The Cooper Companies (NYSE, USD): minus 0.82 percent, P/E 18.53, market capitalization USD 10.6 billion

Bausch Health Companies (NYSE, USD): minus 1.79 percent, P/E minus 2.05, market capitalization USD 2.3 billion

Next report is November 10

EarningsToday lists November 10, 2026 as Alcon's next scheduled report date. The calendar date gives the current valuation its next defined corporate checkpoint.

Trading stays above the prior close

Lang & Schwarz recorded EUR 57.02 for Alcon at 3:20 p.m. CEST on October 9, 2026, versus the EUR 56.35 prior close from October 8, 2026. The bid was EUR 57.00 and the ask was EUR 57.04.

The further course of trading is shown by the continuously updated real-time quote of Alcon stock.